ArticleAnnals of neurology2026
Change in Amyloid-β Deposition and Diffusion Tensor Image Analysis along the Perivascular Space Index in Incident Neurodegenerative Disease.
Article in Annals of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveWe investigated the longitudinal association between cognitive decline, amyloid-β deposition, and perivascular diffusivity using diffusion tensor image analysis along the perivascular space (DTI-ALPS) index.
methodsThis 2-year longitudinal study included 211 participants from the Alzheimer's Disease Neuroimaging Initiative, categorized into sustained cognitively normal, incident mild cognitive impairment, persistent mild cognitive impairment, and incident Alzheimer's disease (AD). The DTI-ALPS index and amyloid-β standardized uptake value ratio (SUVR) from amyloid positron emission tomography were obtained at baseline and follow-up. Linear mixed-effects models were used to examine longitudinal changes in the DTI-ALPS index and their associations with cognitive decline and amyloid-β accumulation. Multiple mediation analyses were performed to evaluate whether amyloid burden and gray matter atrophy mediated the relationship between changes in the DTI-ALPS index and cognitive performance. Additional analyses assessed the effect of baseline amyloid-β positivity.
resultsThe incident mild cognitive impairment and incident AD groups showed greater longitudinal declines in the DTI-ALPS index than the sustained cognitively normal group. Longitudinal reductions in the DTI-ALPS index were associated with greater cognitive decline and increased amyloid-β accumulation. Mediation analyses showed no significant indirect effects through SUVR or gray matter volume. Although baseline amyloid-β positivity alone was not associated with longitudinal DTI-ALPS changes, significant interactions with clinical progression were observed.
interpretationLongitudinal alterations in the DTI-ALPS index are associated with cognitive decline and amyloid-β accumulation. These findings support the DTI-ALPS index as a non-invasive imaging marker reflecting disease progression in AD. ANN NEUROL 2026;100:559-571.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.